| Product Code: ETC9388030 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Oncology-Cancer Drugs Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Oncology-Cancer Drugs Market - Industry Life Cycle |
3.4 South Africa Oncology-Cancer Drugs Market - Porter's Five Forces |
3.5 South Africa Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 South Africa Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 South Africa Oncology-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in South Africa |
4.2.2 Growing adoption of advanced oncology treatments |
4.2.3 Rising investments in healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost of oncology-cancer drugs |
4.3.2 Regulatory challenges and approval processes |
4.3.3 Limited access to specialized oncology care in certain regions |
5 South Africa Oncology-Cancer Drugs Market Trends |
6 South Africa Oncology-Cancer Drugs Market, By Types |
6.1 South Africa Oncology-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F |
6.1.6 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.2 South Africa Oncology-Cancer Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.2.4 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.5 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.6 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.7 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.8 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
6.2.9 South Africa Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
7 South Africa Oncology-Cancer Drugs Market Import-Export Trade Statistics |
7.1 South Africa Oncology-Cancer Drugs Market Export to Major Countries |
7.2 South Africa Oncology-Cancer Drugs Market Imports from Major Countries |
8 South Africa Oncology-Cancer Drugs Market Key Performance Indicators |
8.1 Patient survival rates |
8.2 Adoption rate of innovative cancer treatments |
8.3 Number of clinical trials conducted in South Africa |
8.4 Availability of oncology-cancer drugs in public healthcare facilities |
8.5 Investment in oncology research and development in the country. |
9 South Africa Oncology-Cancer Drugs Market - Opportunity Assessment |
9.1 South Africa Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 South Africa Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 South Africa Oncology-Cancer Drugs Market - Competitive Landscape |
10.1 South Africa Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 South Africa Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here